Table 1. Patient demographics, tumour details, management and outcome of screen, and interval cancers by Dukes' stage.
| |
Dukes' stage A |
Dukes' stage B |
Dukes' stage C |
Dukes' stage D |
||||
|---|---|---|---|---|---|---|---|---|
| Screen, n=125 | Interval, n=36 | Screen, n=81 | Interval, n=51 | Screen, n=89 | Interval, n=56 | Screen, n=21 | Interval, n=44 | |
| Mean age, years (s.e.m.) |
64.75 (0.28) |
65.80 (0.46) |
64.88 (0.35) |
65.99 (0.39) |
65.49 (0.32) |
65.77 (0.38) |
64.05 (0.71) |
65.24 (0.45) |
|
Gender | ||||||||
| Male | 87 (69.6%) | 20 (55.6%) | 63 (77.8%) | 34 (66.7%) | 66 (74.2%) | 31 (55.4%) | 15 (71.4%) | 29 (65.9%) |
| Female |
38 (30.4%) |
16 (44.4%) |
18 (22.2%) |
17 (33.3%) |
23 (25.8%) |
25 (44.6%) |
6 (28.6%) |
15 (34.1%) |
|
ASA grade | ||||||||
| 1–2 | 70 (77.8%) | 19 (73.1%) | 51 (77.3%) | 37 (78.7%) | 65 (85.5%) | 35 (77.8%) | 9 (75.0%) | 9 (52.9%) |
| 3–5 |
20 (22.2%) |
7 (26.9%) |
15 (22.7%) |
10 (21.3%) |
11 (14.5%) |
10 (22.2%) |
3 (25.0%) |
8 (47.1%) |
|
Index of multiple deprivation quintile category | ||||||||
| Most affluent | 16 (12.8%) | 10 (27.8%) | 4 (4.9%) | 8 (15.7%) | 11 (12.4%) | 9 (16.1%) | 0 (0.0%) | 3 (6.8%) |
| 2 | 25 (20.0%) | 3 (8.3%) | 14 (17.3%) | 6 (11.8%) | 17 (19.1%) | 11 (19.6%) | 5 (23.8%) | 5 (11.4%) |
| 3 | 27 (21.6%) | 9 (25.0%) | 20 (24.7%) | 15 (29.4%) | 19 (21.3%) | 15 (26.8%) | 3 (14.3%) | 13 (29.5%) |
| 4 | 24 (19.2%) | 6 (16.7%) | 20 (24.7%) | 10 (19.6%) | 21 (23.6%) | 12 (21.4%) | 10 (47.6%) | 7 (15.9%) |
| Most deprived |
33 (26.4%) |
8 (22.2%) |
23 (28.4%) |
12 (23.5%) |
21 (23.6%) |
9 (16.1%) |
3 (14.3%) |
16 (36.4%) |
|
Tumour location | ||||||||
| Distal to splenic flexure | 108 (86.4%) | 30 (83.3%) | 54 (66.7%) | 29 (56.9%) | 69 (77.5%) | 34 (60.7%) | 16 (76.2%) | 30 (68.2%) |
| Splenic flexure and proximal |
17 (13.6%) |
6 (16.7%) |
27 (33.3%) |
22 (43.1%) |
20 (22.5%) |
22 (39.3%) |
5 (23.8%) |
14 (31.8%) |
|
T stage | ||||||||
| pT1 | 86 (68.8%) | 22 (61.1%) | 6 (6.7%) | 3 (5.4%) | 0 (0.0%) | 0 (0.0%) | ||
| pT2 | 39 (31.2%) | 14 (38.9%) | 11 (12.4%) | 4 (7.1%) | 1 (8.3%) | 0 (0.0%) | ||
| pT3 | 70 (86.4%) | 36 (70.6%) | 51 (57.3%) | 28 (50.0%) | 5 (41.7%) | 4 (40.0%) | ||
| pT4 | 11 (13.6%) | 15 (29.4%) | 20 (22.5%) | 21 (37.5%) | 6 (50.0%) | 6 (60.0%) | ||
| pTx |
|
|
|
|
1 (1.1%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
|
Type of procedure | ||||||||
| Resective | 87 (69.6%) | 32 (88.9%) | 81 (100.0%) | 51 (100.0%) | 89 (100.0%) | 56 (100.0%) | 12 (57.1%) | 10 (22.7%) |
| Local excision | 38 (30.4%) | 4 (11.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Palliative | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 3 (14.3%) | 8 (18.2%) |
| No procedure |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
6 (28.6%) |
26 (59.1%) |
|
30-Day mortality | ||||||||
| Yes | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.1%) | 1 (1.8%) | 0 (0.0%) | 5 (11.4%) |
| No | 125 (100.0%) | 36 (100.0%) | 81 (100.0%) | 51 (100.0%) | 88 (98.9%) | 55 (98.2%) | 21 (100.0%) | 39 (88.6%) |
Abbreviation: ASA=American Society of Anaesthesiologists.